Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patients

Journal of Nephrology

Volumn 26, Issue 3, 2013, Pages 556-563

  Bargnoux, Anne Sophie ^a,b   Cristol, Jean Paul ^a,b   Jaussent, Isabelle ^c   Chalabi, Lotfi ^d   Bories, Pierre ^e   Dion, Jean Jacques ^f   Henri, Patrick ^g   Delage, Martine ^a   Dupuy, Anne Marie ^a   Badiou, Stéphanie ^a,b   Canaud, Bernard ^a,b,d   Morena, Marion ^a,b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b University Montpellier 1 et 2   (France)

^c INSERM   (France)

^d Jacques Mirouze Clinic   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f Manchester hospital   (France)

^g CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Anemia; Erythropoiesis stimulating agents; Hemodialysis; Oxidative stress; Vitamin E coated polysulfone membrane

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MYELOPEROXIDASE; POLYSULFONE; RECOMBINANT ERYTHROPOIETIN; SUPEROXIDE DISMUTASE;

ADULT; ANEMIA; ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; CLINICAL ARTICLE; CLINICAL TRIAL; DIALYSIS MEMBRANE; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; MULTICENTER STUDY; OXIDATIVE STRESS; PROSPECTIVE STUDY;

ANEMIA; ANTIOXIDANTS; COATED MATERIALS, BIOCOMPATIBLE; ERYTHROCYTES; ERYTHROPOIETIN; FEMALE; HUMANS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; OXIDATIVE STRESS; POLYMERS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SULFONES; VITAMIN E;

EID: 84878002514     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000195     Document Type: Article

References (37)

1. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62(5):1524-1538.
2. Morena M, Delbosc S, Dupuy AM, Canaud B, Cristol JP. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysisassociated inflammation. Hemodial Int. 2005;9(1):37-46.
3. Terrier N, Jaussent I, Dupuy AM, et al. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients. Nephrol Dial Transplant. 2008;23(1):345-353.
4. Morena M, Cristol JP, Canaud B. Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif. 2000;18(3):191-199.
5. Badiou S, Cristol JP, Morena M, et al. Vitamin E supplementation increases LDL resistance to ex vivo oxidation in hemodialysis patients. Int J Vitam Nutr Res. 2003;73(4):290-296.
6. Mydlík M, Derzsiová K, Rácz O, Sipulová A, Lovásová E, Petrovicová J. A modified dialyzer with vitamin E and antioxidant defense parameters. Kidney Int Suppl. 2001;78(s78):S144-S147.
7. Galli F, Rovidati S, Chiarantini L, Campus G, Canestrari F, Buoncristiani U. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int. 1998;54(2):580-589.
8. Kirmizis D, Papagianni A, Belechri AM, Memmos D. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis. Nephrol Dial Transplant. 2011;26(7):2296-2301.
9. Takouli L, Hadjiyannakos D, Metaxaki P, et al. Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress. Ren Fail. 2010;32(3):287-293.
10. Sosa MA, Balk EM, Lau J, et al. A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant. 2006;21(10):2825-2833.
11. Tsuruoka S, Kawaguchi A, Nishiki K, et al. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am J Kidney Dis. 2002;39(1):127-133.
12. Morena M, Gausson V, Mothu N, et al. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile. Blood Purif. 2008;26(3):300-310.
13. Locatelli F, Aljama P, Bárány P, et al; European Best Practice Guidelines Working Group. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(Suppl 2):ii1-ii47.
14. Locatelli F, Covic A, Eckardt KU, Wiecek A, Vanholder R; ERA-EDTA ERBP Advisory Board. Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2009;24(2):348-354.
15. Agence Française de Sécurité Sanitaire des Produits de Santé (AFFSAPS). [Treatment of anemia caused by chronic kidney failure in adults] [article in French]. Nephrol Ther. 2005;1(Suppl 1):S1-S48.
16. Panichi V, Rosati A, Bigazzi R, et al; RISCAVID Study Group. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study. Nephrol Dial Transplant. 2011;26(8):2641-2648.
17. Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant. 1997;12(11):2312-2317.
18. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5):1304-1313.
19. Morena M, Cristol JP, Bosc JY, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant. 2002;17(3):422-427.
20. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158-169.
21. National Committee for Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory. NCCLS document C28-A2. 2nd ed. Wayne, PA: NCCLS; 2000.
22. Satoh M, Yamasaki Y, Nagake Y, et al. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int. 2001;59(5):1943-1950.
23. Clermont G, Lecour S, Cabanne JF, et al. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med. 2001;31(2):233-241.
24. Sasaki M. Development of vitamin E-modified polysulfone membrane dialyzers. J Artif Organs. 2006;9(1):50-60.
25. Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant. 2005;20(12):2775-2782.
26. Drüeke T. Hyporesponsiveness to recombinant human erythropoietin. Nephrol Dial Transplant. 2001;16(Suppl 7):25-28.
27. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis. 2003;42(4):761-773.
28. López-Gómez JM, Portolés JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl. 2008;(111):S75-S81.
29. Kumbasar A, Gursu M, Kaya C, et al. The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients. J Nephrol. 2012 Feb 1. [Epub ahead of print].
30. Usberti M, Gerardi G, Micheli A, et al. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients. J Nephrol. 2002;15(5):558-564.
31. Kobayashi S, Moriya H, Aso K, Ohtake T. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int. 2003;63(5):1881-1887.
32. Cruz DN, De Cal M, Garzotto F, et al. Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: an Italian multicenter study. Int J Artif Organs. 2008;31(6):545-552.
33. Andrulli S, Di Filippo S, Manzoni C, et al. Effect of synthetic vitamin E-bonded membrane on responsiveness to erythropoiesis-stimulating agents in hemodialysis patients: a pilot study. Nephron Clin Pract. 2010;115(1):c82-c89.
34. Panichi V, Rosati A, Paoletti S, et al. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial. Blood Purif. 2011;32(1):7-14.
35. Weinstein T, Chagnac A, Korzets A, et al. Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress. Nephrol Dial Transplant. 2000; 15(6):883-887.
36. Gallucci MT, Lubrano R, Meloni C, et al. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients. Clin Nephrol. 1999;52(4):239-245.
37. Bonnefont-Rousselot D, Lehmann E, Jaudon MC, Delattre J, Perrone B, Rechke JP. Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: effect of the use of a vitamin E-coated dialysis membrane. Nephrol Dial Transplant. 2000;15(12):2020-2028.